MYRIAD GENETICS, INC. (MYGN) Net margin 2016–2025
MYRIAD GENETICS, INC. (MYGN) net profit margin by fiscal year — reported net income divided by reported revenue.
-44.4%FY2025 · since FY2016: 15.8% → -44.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -44.4% | -29.2 pp |
| FY2024 | -15.2% | +19.8 pp |
| FY2023 | -34.9% | -18.4 pp |
| FY2022 | -16.5% | -12.6 pp |
| FY2021 | -3.9% | +36.2 pp |
| FY2020 | -40.1% | -40.7 pp |
| FY2019 | 0.5% | -17.4 pp |
| FY2018 | 17.9% | +15.5 pp |
| FY2017 | 2.4% | -13.4 pp |
| FY2016 | 15.8% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice